Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cyteir Therapeutics Inc.

    NASDAQ: CYT · Real-Time Price · USD
    3.02
    -0.07 (-2.27%)
    At close: Mar 15, 2024, 9:00 PM

    Cyteir Therapeutics Statistics

    Share Statistics

    Cyteir Therapeutics has 36M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 36M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 10.83M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,399

    FTD / Avg. Volume

    n/a
    		 0.83%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -1.32 and the forward PE ratio is null. Cyteir Therapeutics's PEG ratio is 0.03.

    PE Ratio

    n/a
    		 -1.32

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.4

    P/FCF Ratio

    n/a
    		 -1.36

    PEG Ratio

    n/a
    		 0.03
    Financial Ratio History

    Enterprise Valuation

    Cyteir Therapeutics has an Enterprise Value (EV) of -88.03M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 1.85

    EV / EBIT

    n/a
    		 2.07

    EV / FCF

    n/a
    		 2.05

    Financial Position

    The company has a current ratio of 28.07, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 28.07

    Quick Ratio

    n/a
    		 28.07

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 72.11

    Financial Efficiency

    Return on Equity is -30.05% and Return on Invested Capital is -31.23%.

    Return on Equity

    n/a
    		 -30.05%

    Return on Assets

    n/a
    		 -28.68%

    Return on Invested Capital

    n/a
    		 -31.23%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-955,478.26

    Employee Count

    n/a
    		 46

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -2.11M

    Effective Tax Rate

    n/a
    		 4.58%

    Stock Price Statistics

    The stock price has increased by 0.33% in the last 52 weeks. The beta is 0.1, so Cyteir Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.1

    52-Week Price Change

    n/a
    		 0.33%

    50-Day Moving Average

    n/a
    		 3.06

    200-Day Moving Average

    n/a
    		 2.94

    Relative Strength Index (RSI)

    n/a
    		 42.39

    Average Volume (20 Days)

    n/a
    		 167,616

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -1.38M

    Operating Income

    n/a
    		 -48.17M

    Net Income

    n/a
    		 -43.95M

    EBITDA

    n/a
    		 -47.5M

    EBIT

    n/a
    		 -46.73M

    Earnings Per Share (EPS)

    n/a
    		 -1.25
    Full Income Statement

    Balance Sheet

    The company has 147.12M in cash and 889K in debt, giving a net cash position of 146.23M.

    Cash & Cash Equivalents

    n/a
    		 147.12M

    Total Debt

    n/a
    		 889K

    Net Cash

    n/a
    		 146.23M

    Retained Earnings

    n/a
    		 -138.11M

    Total Assets

    n/a
    		 131.01M

    Working Capital

    n/a
    		 124.67M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -42.53M and capital expenditures -312K, giving a free cash flow of -42.84M.

    Operating Cash Flow

    n/a
    		 -42.53M

    Capital Expenditures

    n/a
    		 -312K

    Free Cash Flow

    n/a
    		 -42.84M

    FCF Per Share

    n/a
    		 -1.21
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    CYT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -75.52%

    FCF Yield

    n/a
    		 -73.61%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for CYT.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 9.34

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist